{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:50:29Z","timestamp":1756385429490},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2006,12,1]]},"DOI":"10.1532\/ijh97.06106","type":"journal-article","created":{"date-parts":[[2006,12,22]],"date-time":"2006-12-22T20:10:15Z","timestamp":1166818215000},"page":"421-424","source":"Crossref","is-referenced-by-count":12,"title":["Sacroiliitis as an Initial Manifestation of Acute Myelogenous Leukemia"],"prefix":"10.1007","volume":"84","author":[{"given":"Takumi","family":"Hoshino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arito","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Irisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Handa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norifumi","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamitsu","family":"Karasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Nojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","unstructured":"van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of New York criteria. <i>Arthritis Rheum.<\/i> 1984; 27:361-368."},{"key":"E00002","unstructured":"Yamaguchi A. Tsuchiya N, Mitsui H, et al. Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients. Evidence for a role of peptide-anchoring B pocket. <i>Arthritis Rheum.<\/i> 1995; 38:1672-1677."},{"key":"E00003","unstructured":"Tanvetyanon T, Stiff P. Recurrent steroid-responsive pancreatitis associated with myelodysplastic syndrome and transformations. <i>Leuk Lymphoma.<\/i> 2005; 46:151-154."},{"key":"E00004","unstructured":"Koch B, Kranzhofer N, Pfreundschu M, Pees HW, Trumper L. First manifestations of seronegative spondylarthropathy following autologous stem cell transplantation in HLA-B27-positive patients. <i>Bone Marrow Transplant.<\/i> 2000; 26:673-675."},{"key":"E00005","unstructured":"Bakland G, Nossent H. Acute myelogenous leukaemia following etanercept therapy. <i>Rheumatology.<\/i> 2003; 42:900-917."},{"key":"E00006","unstructured":"Au WY, Hawkins BR, Cheng N, Lie AKW, Liang R, Kwong YL. Risk of haematological malignancies in HLA-B27 carriers. <i>Br J Haematol.<\/i> 2001; 115:320-322."},{"key":"E00007","unstructured":"Hamblin TJ. Immunological abnormalities in myelodysplastic syndromes. <i>Semin Hematol.<\/i> 1996; 33:150-162."},{"key":"E00008","unstructured":"Enright H, Jacob HS, Vercellotti G, Howe R, Belzer M, Miller W. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. <i>Br J Haematol.<\/i> 1995; 91:403-408."},{"key":"E00009","unstructured":"Castro M, Conn DL, Su WP, Garton JP. Rheumatic manifestations in myelodysplastic syndromes. <i>J Rheumatol.<\/i> 1991; 18:721-727."},{"key":"E00010","unstructured":"Billstrom R, Johansson H, Johansson B, Mitelman F. Immunemediated complications in patients with myelodysplastic syndromes\u2014clinical and cytogenetic features. <i>Eur J Haematol.<\/i> 1995; 55:42-48."},{"key":"E00011","unstructured":"Okamoto T, Okada M, Mori A, et al. Correlation between immuno-logical abnormalities and prognosis in myelodysplastic syndrome patients. <i>Int J Hematol.<\/i> 1997; 66:345-351."},{"key":"E00012","unstructured":"Mufti GJ, Figes A, Hamblin TJ, Oscier DG, Copplestone JA. Immunological abnormalities in myelodysplastic syndromes. Serum immunoglobulins and autoantibodies. <i>Br J Haematol.<\/i> 1986; 63:143-147."},{"key":"E00013","unstructured":"Economopoulos T, Economidou J, Giannopoulos G, et al. Immune abnormalities in myelodysplastic syndromes. <i>J Clin Pathol.<\/i> 1985; 38:908-911."}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.06106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2012,12,31]],"date-time":"2012-12-31T10:48:46Z","timestamp":1356950926000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.06106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,1]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,12,1]]}},"alternative-id":["H73V76P484602263"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.06106","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12,1]]}}}